Onvitrelin ucalontide structure
|
Common Name | Onvitrelin ucalontide | ||
---|---|---|---|---|
CAS Number | 1174415-90-7 | Molecular Weight | 3316.94 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C163H243N43O32 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Onvitrelin ucalontideOnvitrelin ucalontide ([Phor18-LHRH (338613)]) is an analogue of luteinizing hormone releasing hormone (LHRH) with antineoplastic activity. Onvitrelin ucalontide is a peptide with sequences of KFAKFAKKFAKFAKKFAKQHWSYGLRPG. Onvitrelin ucalontide effectively inhibits breast cancer, ovarian cancer and prostate cancer xenografts in mouse model[1][2]. |
Name | Onvitrelin ucalontide |
---|
Description | Onvitrelin ucalontide ([Phor18-LHRH (338613)]) is an analogue of luteinizing hormone releasing hormone (LHRH) with antineoplastic activity. Onvitrelin ucalontide is a peptide with sequences of KFAKFAKKFAKFAKKFAKQHWSYGLRPG. Onvitrelin ucalontide effectively inhibits breast cancer, ovarian cancer and prostate cancer xenografts in mouse model[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C163H243N43O32 |
---|---|
Molecular Weight | 3316.94 |